KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $980,000 | +199.7% | 210,666 | +277.0% | 0.01% | +233.3% |
| Q4 2016 | $327,000 | +10.1% | 55,878 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $297,000 | -21.8% | 55,878 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $380,000 | +45.6% | 55,878 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $261,000 | -23.9% | 55,878 | -17.8% | 0.00% | -33.3% |
| Q4 2015 | $343,000 | +41.7% | 67,948 | -1.0% | 0.00% | +50.0% |
| Q3 2015 | $242,000 | -85.8% | 68,662 | -59.8% | 0.00% | -84.6% |
| Q2 2015 | $1,703,000 | +3.0% | 170,690 | +31.3% | 0.01% | +8.3% |
| Q1 2015 | $1,654,000 | -17.7% | 129,956 | -8.5% | 0.01% | -20.0% |
| Q4 2014 | $2,010,000 | +3.4% | 142,047 | +0.5% | 0.02% | 0.0% |
| Q3 2014 | $1,944,000 | -14.7% | 141,360 | -4.6% | 0.02% | -6.2% |
| Q2 2014 | $2,279,000 | – | 148,171 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |